Karyopharm and Menarini Group Receive Full Marketing Authorisa... - 22 July 2022 00:03

NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire-AsiaNet/ -- – Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 – Karyopharm Therap...

  Oncoshot Enters Collaboration Agreement With Omico (Australian... - 20 July 2022 00:35

SINGAPORE, July 19, 2022 /PRNewswire-AsiaNet/ – Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented at the event yesterday by Dr Huren Sivaraj, CEO and co-founder of Oncoshot, and Prof David ...

  llumina Among First in the World to Receive Approval of Scienc... - 19 July 2022 19:51

SINGAPORE, July 19, 2022 /PRNewswire-AsiaNet/ -- The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it i...

  DarwinHealth Publishes Results of Novel, Viral Checkpoint-base... - 19 July 2022 19:00

NEW YORK, July 19, 2022 /PRNewswire-Asianet/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the July 19, 2022 online publication in Communications Biology (a Nature Portfolio peer-reviewed journal) of a foundational paper focused on new approac...

  SHL Medical announces plans for a new manufacturing site in th... - 19 July 2022 00:45

NORTH CHARLESTON, S.C., July 18, 2022 /PRNewswire-AsiaNet/ -- SHL Medical (hereinafter referred to as "SHL") has revealed plans for a new manufacturing site in the US, in response to the growing market demand for its autoinjector product portfolio. The decision stems from SHL's strategic assessments in exten...

  Zymo Research's DNA/RNA Shield(TM) Inactivates Monkeypox for t... - 15 July 2022 09:42

IRVINE, Calif., July 15, 2022 /PRNewswire-AsiaNet/ -- Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg, Germany, demonstrated data showing their DNA/RNA Shield(TM) Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus...

  Nefertiti Greene Joins Mars Petcare to Run New Science & Diagn... - 15 July 2022 00:27

BRUSSELS, July 14, 2022 /PRNewswire-AsiaNet/-- - Mars Petcare announces former Johnson & Johnson executive Nefertiti Greene as member of Global Petcare Leadership team - Greene will head new division within Mars Petcare, Science & Diagnostics - Demonstrates company's deep commitment to adva...

  Oncoshot Receives Funding To Expand Cancer Data Sharing Capabi... - 14 July 2022 18:03

SINGAPORE, July 14, 2022 /PRNewswire-AsiaNet/ -- Oncoshot today announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors. This fund...

  LIMACORPORATE AND ORTHOFIX MEDICAL ANNOUNCE PARTNERSHIP TO PRO... - 13 July 2022 21:56

VILLANOVA, Italy , July 13, 2022 /PRNewswireAsiaNet/ -- Limacorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, and Orthofix Medical Inc, a global medical device company with a spine and orthopedics focus, today announced a licensing partnership fo...

  SoniVie Announces successful procedure with TIVUS system on fi... - 13 July 2022 14:00

TEL AVIV, Israel, July 13, 2022 /PRNewswire-AsiaNet/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS(TM)) System to treat a variety of hypertensive disorders, announced that on May 30th 2022 the first patient was treated with its Renal Artery D...